Pharmaco - Press Releases

Date	Title	Company
20-Jul-2022	Spexis announces business update call to be held on July 28th	Spexis AG
19-Jul-2022	Essential Pharma makes strong progress in its ESG performance and now exceeds sector benchmarks	Essential Pharma
19-Jul-2022	Roche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virus	Roche
19-Jul-2022	ForSight Robotics Raises $55 Million in Series A Round to Develop World’s First Fully Robotic Cataract Surgery Procedure	ForSight Robotics
19-Jul-2022	APONTIS PHARMA and Midas Pharma agree on further development partnership for the market launch of a single pill with pan-European intellectual property rights	APONTIS PHARMA AG
18-Jul-2022	Apaxen Appoints Graham K. Dixon as Chairman and Prepares for Clinical Testing of its Lead Inflammasome Inhibitor	B3C newswire
18-Jul-2022	Roche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virus	Roche
18-Jul-2022	XPhyto Therapeutics Corp.: XPhyto Pursues Potential Application of its Oral Dissolvable Biosensor Inflammation Test for Buprenorphine-related Dental Disease	XPhyto Therapeutics Corp.
18-Jul-2022	Relief Therapeutics Announces that its Collaboration Partner has Resubmitted the ACER-001 (sodium phenylbutyrate) New Drug Application (NDA) to the FDA for the treatment of urea cycle disorders (UCDs)	Relief Therapeutics Holding SA
18-Jul-2022	Relief Therapeutics Appoints Serene Forte, Ph.D., MPH, as Senior Vice President, Head of Genetic Medicine	Relief Therapeutics Holding SA
15-Jul-2022	IGEA Pharma N.V.: IGEA to get SIX further approval to the 2021 annual report disclosure	IGEA Pharma N.V.
15-Jul-2022	Weekly Pharma & Life Science News Round-Up: 11th – 15th July	PharmiWeb
15-Jul-2022	15th Edition Portfolio Management And Pipeline Optimization For Generics	marcus evans
15-Jul-2022	Polpharma Biologics Announces EMA Acceptance of Marketing Authorization Application for Proposed Biosimilar Natalizumab	B3C newswire
14-Jul-2022	Drägerwerk AG & Co. KGaA: Preliminary figures for H1 2022: net sales and earnings significantly below prior year despite strong order entry – guidance confirmed due to expected business recovery in H2	Drägerwerk AG & Co. KGaA
14-Jul-2022	83% fewer vaccinated women hospitalised during pregnancy – but only Omicron jab can maintain success	New Office for National Statistics
14-Jul-2022	Nanoform and Pharmanovia to breathe new life into iconic medicines	Nanoform Finland Plc
14-Jul-2022	Grünenthal acquires testosterone treatment Nebido™ from Bayer	Bayer
13-Jul-2022	Resaphene Suisse AG: FDA approval process for tinnitus therapy tinniwell continues (news with additional features)	Resaphene Suisse AG
13-Jul-2022	PharmiWeb.Jobs Welcomes Excelya	PharmiWeb.Jobs